Efexor XL 225 mg hard prolonged-release capsules

Kraj: Wielka Brytania

Język: angielski

Źródło: myHealthbox

Składnik aktywny:

venlafaxine hydrochloride,

Dostępny od:

Pfizer Limited

Kod ATC:

NO6AX16

INN (International Nazwa):

venlafaxine hydrochloride,

Dawkowanie:

225 mg

Forma farmaceutyczna:

Hard prolonged-release capsule.

Droga podania:

oral use

Sztuk w opakowaniu:

7, 10, 14, 15, 20, 28, 30, 50, 56, 60, 98, 100

Typ recepty:

POM - Prescription Only Medicine

Wyprodukowano przez:

Pfizer Ireland Pharmaceuticals

Grupa terapeutyczna:

Other antidepressants

Wskazania:

Treatment of major depressive episodes. For prevention of recurrence of major depressive episodes. Treatment of generalised anxiety disorder. Treatment of social anxiety disorder. Treatment of panic disorder, with or without agoraphobia.

Status autoryzacji:

Authorised

Data autoryzacji:

2015-11-26

Ulotka dla pacjenta

 
Page 1 of 11

PACKAGE LEAFLET: INFORMATION FOR THE USER 

EFEXOR XL 225 MG HARD PROLONGED-RELEASE CAPSULES 

Venlafaxine 

IMPORTANT THINGS YOU SHOULD KNOW ABOUT EFEXOR XL  

PLEASE READ ALL OF THIS LEAFLET BEFORE YOU START TO TAKE YOUR
MEDICINE BECAUSE IT CONTAINS IMPORTANT 
INFORMATION FOR YOU. 

 
EFEXOR XL IS USED TO TREAT DEPRESSION, SEVERE AND
PERSISTENT ANXIETY KNOWN AS GENERALISED 
ANXIETY DISORDER (GAD), SOCIAL ANXIETY DISORDER (ALSO
KNOWN AS SOCIAL PHOBIA) AND PANIC 
DISORDER (PANIC ATTACKS) 

 
EFEXOR XL IS NOT FOR USE IN CHILDREN AND ADOLESCENTS – see
in section 2 ‘ Children and 
adolescents’  

IF YOU HAVE ANY CONCERNS ABOUT HOW YOU FEEL, OR ABOUT
THIS MEDICATION, IT IS IMPORTANT THAT YOU TALK 
TO YOUR DOCTOR - EVEN IF YOU FEEL ANXIOUS OR WORRIED ABOUT DOING
SO.   
You may find it helpful to tell a friend or relative that you
are depressed or suffering from an anxiety 
disorder, and that you have been prescribed this
medication; it might be useful to show them this leaflet. 

 
EFEXOR XL MAY NOT START TO WORK IMMEDIATELY.  Some
people taking antidepressants may feel 
worse before feeling better.  Your doctor may ask to see you
again a couple of weeks after you 
start treatment and then regularly until you start to
feel well again.  Tell your doctor if you do not 
start to feel better.  

 
SOME PEOPLE WHO ARE DEPRESSED MAY THINK OF HARMING OR KILLING
THEMSELF.  IF THIS HAPPENS 
YOU SHOULD SEE YOUR DOCTOR OR GO TO A HOSPITAL STRAIGHT
AWAY – see in section 2 ‘Thoughts of 
suicide and worsening of your depression or anxiety disorder’ 

 
IF YOU TAKE TOO MANY CAPSULES IT IS IMPORTANT TO
SEEK IMMEDIATE MEDICAL ATTENTION, EVEN IF 
YOU FEEL WELL, BECAUSE OF THE RISK OF SERIOUS SIDE EFFECTS 

 
DO NOT STOP TAKING EFEXOR XL OR CHANGE YOUR
DOSE WITHOUT THE ADVICE OF YOUR

Charakterystyka produktu

(IH[RU;/PJ&DSVXOHV
6XPPDU\RI3URGXFW&KDUDFWHULVWLFV8SGDWHG1RY_3IL]HU/LPLWHG
1DPHRIWKHPHGLFLQDOSURGXFW
(IH[RU;/PJKDUGSURORQJHGUHOHDVHFDSVXOHV
4XDOLWDWLYHDQGTXDQWLWDWLYHFRPSRVLWLRQ
(DFKSURORQJHGUHOHDVHFDSVXOHFRQWDLQVPJRIYHQODID[LQHK\GURFKORULGHHTXLYDOHQWWRPJRIYHQODID[LQH
IUHHEDVH
)RUWKHIXOOOLVWRIH[FLSLHQWVVHHVHFWLRQ
3KDUPDFHXWLFDOIRUP
+DUGSURORQJHGUHOHDVHFDSVXOH
/LJKWJUH\RSDTXHFDSDQGGDUNRUDQJHRSDTXHERG\FDSVXOHVSULQWHGLQZKLWHZLWK
: DQG  KDUGJHODWLQFDSVXOH
VL]HHOPP[PP
&OLQLFDOSDUWLFXODUV
7KHUDSHXWLFLQGLFDWLRQV
7UHDWPHQWRIPDMRUGHSUHVVLYHHSLVRGHV
)RUSUHYHQWLRQRIUHFXUUHQFHRIPDMRUGHSUHVVLYHHSLVRGHV
7UHDWPHQWRIJHQHUDOLVHGDQ[LHW\GLVRUGHU
7UHDWPHQWRIVRFLDODQ[LHW\GLVRUGHU
7UHDWPHQWRISDQLFGLVRUGHUZLWKRUZLWKRXWDJRUDSKRELD
3RVRORJ\DQGPHWKRGRIDGPLQLVWUDWLRQ
3RVRORJ\
0DMRUGHSUHVVLYHHSLVRGHV
7KHUHFRPPHQGHGVWDUWLQJGRVHIRUSURORQJHGUHOHDVHYHQODID[LQHLVPJJLYHQRQFHGDLO\3DWLHQWVQRWUHVSRQGLQJWR
WKHLQLWLDOPJGD\GRVHPD\EHQHILWIURPGRVHLQFUHDVHVXSWRDPD[LPXPGRVHRIPJGD\'RVDJHLQFUHDVHV
FDQEHPDGHDWLQWHUYDOVRIZHHNVRUPRUH,IFOLQLFDOO\ZDUUDQWHGGXHWRV\PSWRPVHYHULW\GRVHLQFUHDVHVFDQEH
PDGHDWPRUHIUHTXHQWLQWHUYDOVEXWQRWOHVVWKDQGD\V
%HFDXVHRIWKHULVNRIGRVHUHODWHGDGYHUVHHIIHFWVGRVHLQFUHPHQWVVKRXOGEHPDGHRQO\DIWHUDFOLQLFDOHYDOXDWLRQ
VHHVHFWLRQ7KHORZHVWHIIHFWLYHGRVHVKRXOGEHPDLQWDLQHG
3DWLHQWVVKRXOGEHWUHDWHGIRUDVXIILFLHQWSHULRGRIWLPHXVXDOO\VHYHUDOPRQWKVRUORQJHU7UHDWPHQWVKRXOGEH
UHDVVHVVHGUHJXODUO\RQDFDVHE\FDVHEDVLV/RQJHUWHUPWUHDWPHQWPD\DOVREHDSSURSULDWHIRUSUHYHQWLRQRI
UHFXUUHQFHRIPDMRUGHSUHVVLYHHSLVRGHV0'(,QPRVWRIWKHFDVHVWKHUHFRPPHQGHGGRVHLQSUHYHQWLRQRI
UHFXUUHQFHRI0'(LVWKHVDPHDVWKHRQHXVHGGXULQJWKHFXUUHQWHSLVRGH
$QWLGHSUHVVLYHPHGLFLQDOSURGXFWVVKRXOGFRQWLQXHIRUDWOHDVWVL[PRQWKVIROORZLQJ